Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials

Emma Guttman‐Yassky, Kenji Kabashima, Margitta Worm, Paula Carolina Luna, Hwanhee Hong, Raj Chovatiya, Jonathan A. Bernstein, Johannes S. Kern, Benjamin D. Ehst, Nina Magnolo, Pedro Herranz, Linda Stein Gold, Howard Sofen, Andrew Pink, Ehsanollah Esfandiari, Takahiro Arai, Yiping Yang, Rebecca Shi, Carolina Barragan, Greg Kricorian, Liat Schwartz-Sagi, Robert Bissonnette